How long does nausea from Wegovy last — and what the evidence says

What the STEP 1 trial data actually show about timing

The STEP 1 trial (68 weeks, nearly 2,000 adults, published in the New England Journal of Medicine) remains the primary evidence base for semaglutide 2.4 mg in weight management. Nausea was reported by roughly 44% of participants in the semaglutide group. Crucially, it was classified as mild or moderate in the vast majority of cases, and it was not persistent across the whole treatment period. The highest rates clustered during the dose-escalation phase (the months when the weekly dose steps upward from 0.25 mg toward 2.4 mg) and declined markedly once participants reached and held their maintenance dose.

What this tells you in practical terms: nausea is not a sign that the medicine is wrong for you. It is a predictable pharmacological response to semaglutide slowing gastric emptying, an effect that the gut's own receptors adjust to over time. If you are wondering how long nausea tends to last with Wegovy, the trial data suggest most participants who reported it early were not still flagging it as a significant problem by mid-trial. If you want a broader picture of how gastrointestinal effects change over the full treatment course, the full side-effect timeline for Wegovy covers that in detail.

The dose-increase pattern: why nausea can return each time

Semaglutide is titrated gradually, a starting dose considerably lower than the eventual maintenance level, stepped up roughly every four weeks by a prescriber. The NHS describes this schedule precisely in its patient information for semaglutide, and it exists precisely to reduce gastrointestinal discomfort during the adjustment period.

Even so, each increase asks your digestive system to readjust. Many people feel nausea settle at one dose, then notice it returning mildly when they move to the next level. This is normal. The same two-to-four-week window typically applies at each step. If nausea at a particular dose feels genuinely unmanageable, that is a conversation for your prescriber, sometimes staying at a lower dose for longer is the right clinical call. Our prescribers at nume cover this as part of every consultation; you can read more about managing these symptoms on our practical guide to reducing nausea on Wegovy.

Worth knowing: nausea tends to be worse on an empty stomach. Eating a small, bland meal before your injection day, staying well hydrated, and avoiding rich or fatty food in the 24 hours after injecting are practical steps many patients find helpful, though the specifics of what works for you are worth discussing with your clinical team.

When nausea from Wegovy is a signal to get medical help

Ordinary nausea is uncomfortable. Certain symptoms are not ordinary, and the distinction matters. Contact a doctor or call 111 promptly if you experience:

• Severe, persistent abdominal pain, particularly if it spreads to your back, this pattern can indicate acute pancreatitis, which the MHRA identified as a known but infrequent serious risk in its January 2026 Drug Safety Update for GLP-1 medicines. MHRA Drug Safety Updates are publicly searchable if you want to read the full communication.
• Vomiting that is frequent enough to prevent you keeping fluids down, prolonged dehydration can put strain on the kidneys.
• Signs of an allergic reaction: swelling of the face, lips or throat, difficulty breathing, or a rapid-onset rash.
• Symptoms of gallbladder problems: sharp pain in the upper right abdomen, especially after eating fatty food, sometimes with fever or jaundice.

For anything less urgent (nausea that is making daily life difficult, or that has not improved after several weeks at the same dose) contact your prescribing team rather than stopping the medicine on your own. Stopping abruptly without guidance is rarely the right answer. If you have questions outside of a GP appointment, our aftercare team is available seven days a week.

You can report any suspected side effect, including nausea you think may be more serious than expected, through the MHRA's Yellow Card scheme. Patient reports genuinely inform ongoing regulatory monitoring.

Nausea after stopping Wegovy, a separate question

Some people ask whether nausea continues once they stop taking semaglutide. This is a different pattern: withdrawal-related gastrointestinal symptoms, if they occur, generally resolve within a few days to a week as the medicine clears the body. The more notable change after stopping is typically the return of appetite, not persistent sickness. Our page on nausea after stopping Wegovy goes into that in more depth. If diarrhoea has also been a feature of your experience, the Wegovy diarrhoea timeline is a related read.

If you are considering Wegovy and want to understand the full side-effect picture before starting, our prescribers discuss suitability and likely side effects as part of every consultation. Check your eligibility through a free clinical consultation, no obligation, same-day review by a GPhC-registered prescriber.